|
|
| | 1,4-Butanediol diglycidyl ether Basic information |
| Product Name: | 1,4-Butanediol diglycidyl ether | | Synonyms: | 1,4-Butanediol diglycidyl ether >=95%;1,4-Butanediol diglycidyl ether technical grade, 60%;1,4-Butanediol diglycidyl ether, 98%, 98%;1,4-butandedioldiglycidylether;1,4-Butane diglycidyl ether;1,4-butanediglycidylether;2-([4-(2-Oxiranylmethoxy)butoxy]methyl)oxirane;2,2'-[1,4-Butanediylbis(oxymethylene)]bis[oxirane] | | CAS: | 2425-79-8 | | MF: | C10H18O4 | | MW: | 202.25 | | EINECS: | 219-371-7 | | Product Categories: | Epoxy Diluents;Epoxide Monomers;Monomers;Polymer Science;Oxiranes;Simple 3-Membered Ring Compounds;bc0001;2425-79-8 | | Mol File: | 2425-79-8.mol |  |
| | 1,4-Butanediol diglycidyl ether Chemical Properties |
| | 1,4-Butanediol diglycidyl ether Usage And Synthesis |
| Description | 1,4-Butanediol diglycidyl ether is a reactive diluent in
epoxy resins. | | Chemical Properties | Clear yellow liquid | | Uses | 1,4-Butanediol diglycidyl ether is used for preparing amylose, xylan and hydroxyethyl-cellulose, to cross link polyethylenimine which also serves as a hole-blocking layer in organic solar cells, to cross link hyaluronic acid into hydrogels and for the activation of soluble dextran polymers. It is the most commonly used homobifunctional epoxide compound | | Uses | | | Production Methods | The compound results from condensation of butanediol with
epichlorohydrin followed by dehydrochlorination with caustic. | | General Description | Clear pale yellow liquid. | | Air & Water Reactions | Hygroscopic. Water soluble | | Reactivity Profile | 1,4-Butanediol diglycidyl ether reacts with acids. | | Fire Hazard | 1,4-Butanediol diglycidyl ether is combustible. | | Flammability and Explosibility | Non flammable | | Contact allergens | This substance is a reactive diluent in epoxy resins | | Carcinogenicity | A2 year dermal cancer bioassay
was conducted in CF1 mice at doses of 0%, 0.05%, and 0.2%
in acetone . Treatment did not adversely affect survival,
did not increase the incidence of skin tumors, and did not
result in significant skin irritation. There were no statistically
significant increases in incidence of any systemic tumors,
except for lymphatic tumors in females. Because there was a
high background incidence of this tumor type in CF1 mice
used in the testing laboratory , there was no clear
evidence of 1,4-BDDGE-induced carcinogenicity. |
| | 1,4-Butanediol diglycidyl ether Preparation Products And Raw materials |
|